Instem Past Earnings Performance
Past criteria checks 4/6
Instem has been growing earnings at an average annual rate of 30.1%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 24.2% per year. Instem's return on equity is 6.1%, and it has net margins of 5.4%.
Key information
30.1%
Earnings growth rate
20.8%
EPS growth rate
Healthcare Services Industry Growth | 12.5% |
Revenue growth rate | 24.2% |
Return on equity | 6.1% |
Net Margin | 5.4% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Here's Why We Think Instem (LON:INS) Might Deserve Your Attention Today
Oct 14An Intrinsic Calculation For Instem plc (LON:INS) Suggests It's 29% Undervalued
Aug 31Instem plc (LON:INS) Shares Could Be 45% Below Their Intrinsic Value Estimate
Jan 25Instem plc's (LON:INS) Intrinsic Value Is Potentially 44% Above Its Share Price
Sep 04Is Instem plc's (LON:INS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Mar 03Shareholders Are Thrilled That The Instem (LON:INS) Share Price Increased 190%
Jan 29Calculating The Intrinsic Value Of Instem plc (LON:INS)
Dec 25Revenue & Expenses BreakdownBeta
How Instem makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 62 | 3 | 0 | 0 |
31 Mar 23 | 60 | 4 | 0 | 0 |
31 Dec 22 | 59 | 5 | 0 | 0 |
30 Sep 22 | 56 | 3 | 0 | 0 |
30 Jun 22 | 53 | 2 | 0 | 0 |
31 Mar 22 | 50 | 2 | 0 | 0 |
31 Dec 21 | 46 | 2 | 0 | 0 |
30 Sep 21 | 40 | 2 | 0 | 0 |
30 Jun 21 | 34 | 2 | 0 | 0 |
31 Mar 21 | 31 | 2 | 0 | 0 |
31 Dec 20 | 28 | 2 | 0 | 0 |
30 Sep 20 | 28 | 1 | 0 | 0 |
30 Jun 20 | 28 | 0 | 0 | 0 |
31 Mar 20 | 27 | 0 | 0 | 0 |
31 Dec 19 | 26 | -1 | 0 | 0 |
30 Sep 19 | 25 | 0 | 0 | 0 |
30 Jun 19 | 24 | 2 | 1 | 0 |
31 Mar 19 | 23 | 2 | 1 | 0 |
31 Dec 18 | 23 | 1 | 1 | 0 |
30 Sep 18 | 22 | 1 | 1 | 0 |
30 Jun 18 | 21 | 1 | 1 | 0 |
31 Mar 18 | 21 | 1 | 1 | 0 |
31 Dec 17 | 21 | 1 | 1 | 0 |
30 Sep 17 | 20 | 0 | 1 | 0 |
30 Jun 17 | 20 | 0 | 1 | 0 |
31 Mar 17 | 19 | 1 | 1 | 0 |
31 Dec 16 | 18 | 1 | 1 | 0 |
30 Sep 16 | 18 | 0 | 1 | 0 |
30 Jun 16 | 18 | -1 | 1 | 0 |
31 Mar 16 | 17 | 0 | 1 | 0 |
31 Dec 15 | 16 | 0 | 1 | 0 |
30 Sep 15 | 16 | 0 | 1 | 0 |
30 Jun 15 | 15 | 1 | 1 | 0 |
31 Mar 15 | 14 | 1 | 1 | 0 |
31 Dec 14 | 13 | 0 | 1 | 0 |
30 Sep 14 | 13 | 0 | 1 | 0 |
30 Jun 14 | 12 | 0 | 1 | 0 |
31 Mar 14 | 11 | 0 | 1 | 0 |
31 Dec 13 | 11 | 1 | 1 | 0 |
30 Sep 13 | 11 | 1 | 1 | 0 |
30 Jun 13 | 11 | 1 | 1 | 0 |
31 Mar 13 | 11 | 1 | 1 | 0 |
31 Dec 12 | 11 | 1 | 1 | 0 |
Quality Earnings: INS has a large one-off loss of £1.1M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: INS's current net profit margins (5.4%) are higher than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INS's earnings have grown significantly by 30.1% per year over the past 5 years.
Accelerating Growth: INS's earnings growth over the past year (68.1%) exceeds its 5-year average (30.1% per year).
Earnings vs Industry: INS earnings growth over the past year (68.1%) exceeded the Healthcare Services industry 6.5%.
Return on Equity
High ROE: INS's Return on Equity (6.1%) is considered low.